{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T15:14:59Z","timestamp":1754147699958,"version":"3.41.2"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health","doi-asserted-by":"publisher","award":["K08AI185310"],"award-info":[{"award-number":["K08AI185310"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Clinical science in the field of infectious diseases (ID) moved at a rapid pace in 2024. Among the highlights were multiple trials of new antibiotics and new approaches to prevent infections. Concerning trends, with outbreaks of dengue, measles, mpox, and highly pathogenic avian influenza A in 2024, demonstrate the importance of ID and the continued need for further advances through clinical science. This review highlights some of the most important trials and clinical trends in ID over the past year.<\/jats:p>","DOI":"10.1093\/cid\/ciaf037","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T23:22:15Z","timestamp":1738192935000},"page":"1216-1220","source":"Crossref","is-referenced-by-count":0,"title":["What's Hot This Year in Infectious Diseases Clinical Science"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5788-1481","authenticated-orcid":false,"given":"Jeffrey A","family":"Freiberg","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee ,","place":["USA"]},{"name":"Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center , Nashville, Tennessee ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4664-6328","authenticated-orcid":false,"given":"Patty W","family":"Wright","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"key":"2025071809222949200_ciaf037-B1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(23)02196-7","article-title":"Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials","volume":"403","author":"Wagenlehner","year":"2024","journal-title":"Lancet"},{"key":"2025071809222949200_ciaf037-B2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"author":"GSK","key":"2025071809222949200_ciaf037-B3"},{"author":"Food and Drug Administration","key":"2025071809222949200_ciaf037-B4"},{"key":"2025071809222949200_ciaf037-B5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/14787210.2022.2020099","article-title":"All-cause mortality rates in adults with carbapenem-resistant gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies","volume":"20","author":"Lodise","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025071809222949200_ciaf037-B6","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025071809222949200_ciaf037-B7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa2304748","article-title":"Cefepime-taniborbactam in complicated urinary tract infection","volume":"390","author":"Wagenlehner","year":"2024","journal-title":"N Engl J Med"},{"author":"Venatorx Pharmaceuticals","key":"2025071809222949200_ciaf037-B8"},{"key":"2025071809222949200_ciaf037-B9","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/cid\/ciad792","article-title":"A randomized, double-blind, phase 3 safety and efficacy study of ridinilazole versus vancomycin for treatment of Clostridioides difficile infection: clinical outcomes with microbiome and metabolome correlates of response","volume":"78","author":"Okhuysen","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025071809222949200_ciaf037-B10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1473-3099(23)00683-7","article-title":"Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial","volume":"24","author":"Ubals","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025071809222949200_ciaf037-B11","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1056\/NEJMoa2310307","article-title":"Inhaled amikacin to prevent ventilator-associated pneumonia","volume":"389","author":"Ehrmann","year":"2023","journal-title":"N Engl J Med"},{"key":"2025071809222949200_ciaf037-B12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S2213-2600(23)00471-X","article-title":"Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial","volume":"12","author":"Dahyot-Fizelier","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2025071809222949200_ciaf037-B13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"2025071809222949200_ciaf037-B14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","article-title":"Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017","volume":"152","author":"Berr\u00edos-Torres","year":"2017","journal-title":"JAMA Surg"},{"key":"2025071809222949200_ciaf037-B15","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJMoa2301401","article-title":"Trial of vancomycin and cefazolin as surgical prophylaxis in arthroplasty","volume":"389","author":"Peel","year":"2023","journal-title":"N Engl J Med"},{"key":"2025071809222949200_ciaf037-B16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa2309002","article-title":"Oral nirmatrelvir-ritonavir as postexposure prophylaxis for COVID-19","volume":"391","author":"Hammond","year":"2024","journal-title":"N Engl J Med"},{"key":"2025071809222949200_ciaf037-B17","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/cid\/ciad766","article-title":"Effectiveness of prophylactic oral and\/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections: a randomized, double-blind, placebo-controlled trial","volume":"78","author":"Gupta","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025071809222949200_ciaf037-B18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2213-2600(24)00140-1","article-title":"Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial","volume":"12","author":"Little","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2025071809222949200_ciaf037-B19","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"400","author":"Ikuta","year":"2022","journal-title":"Lancet"},{"key":"2025071809222949200_ciaf037-B20","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJMoa2300220","article-title":"Ceftobiprole for treatment of complicated Staphylococcus aureus bacteremia","volume":"389","author":"Holland","year":"2023","journal-title":"N Engl J Med"},{"author":"Food and Drug Administration","key":"2025071809222949200_ciaf037-B21"},{"key":"2025071809222949200_ciaf037-B22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1473-3099(23)00756-9","article-title":"Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial","volume":"24","author":"Kaasch","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025071809222949200_ciaf037-B23","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1207290","article-title":"Targeted versus universal decolonization to prevent ICU infection","volume":"368","author":"Huang Susan","year":"2013","journal-title":"N Engl J Med"},{"key":"2025071809222949200_ciaf037-B24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/jama.2023.17219","article-title":"Nasal iodophor antiseptic vs nasal mupirocin antibiotic in the setting of chlorhexidine bathing to prevent infections in adult ICUs: a randomized clinical trial","volume":"330","author":"Huang","year":"2023","journal-title":"JAMA"},{"author":"Pan American Health Organization","key":"2025071809222949200_ciaf037-B25"},{"author":"Centers for Disease Control and Prevention","key":"2025071809222949200_ciaf037-B26"},{"author":"Centers for Disease Control and Prevention","key":"2025071809222949200_ciaf037-B27"},{"author":"World Health Organization","key":"2025071809222949200_ciaf037-B28"},{"author":"Centers for Disease Control and Prevention","key":"2025071809222949200_ciaf037-B29"},{"key":"2025071809222949200_ciaf037-B30","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.21091","article-title":"Mpox clinical presentation, diagnostic approaches, and treatment strategies: a review","author":"Titanji","year":"2024","journal-title":"JAMA"},{"author":"National Institutes of Health","key":"2025071809222949200_ciaf037-B31"},{"author":"Centers for Disease Control and Prevention","key":"2025071809222949200_ciaf037-B32"},{"author":"Centers for Disease Control and Prevention","key":"2025071809222949200_ciaf037-B33"},{"author":"US Department of Agriculture","key":"2025071809222949200_ciaf037-B34"},{"author":"Centers for Disease Control and Prevention","key":"2025071809222949200_ciaf037-B35"},{"key":"2025071809222949200_ciaf037-B36","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.15585\/mmwr.mm7344a3","article-title":"Serologic evidence of recent infection with highly pathogenic avian influenza A(H5) virus among dairy workers\u2014Michigan and Colorado, June\u2013August 2024","volume":"73","author":"Mellis","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf037\/61724612\/ciaf037.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/6\/1216\/61724612\/ciaf037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/6\/1216\/61724612\/ciaf037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T13:22:37Z","timestamp":1752844957000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/80\/6\/1216\/7994646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,2,1]]},"published-print":{"date-parts":[[2025,7,18]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf037","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"type":"print","value":"1058-4838"},{"type":"electronic","value":"1537-6591"}],"subject":[],"published-other":{"date-parts":[[2025,6,15]]},"published":{"date-parts":[[2025,2,1]]}}}